Patents by Inventor Matthew Pollack

Matthew Pollack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240099767
    Abstract: A system for treating and/or diagnosing tissue from a tissue surface comprises: a console; an interface assembly; and a mobile device. The mobile device is configured to navigate a tissue surface and can comprise: a first tissue attachment assembly; a second tissue attachment assembly; and at least one articulation assembly. The interface assembly operably connects the console to the mobile device. The console is configured to manipulate the at least one articulation assembly via the interface assembly. The at least one articulation assembly is configured to navigate from a first tissue location to a second tissue location. The mobile device is configured to diagnose and/or treat tissue at the second tissue location. Methods of treating and/or diagnosing tissue are also described.
    Type: Application
    Filed: December 3, 2021
    Publication date: March 28, 2024
    Inventors: Dwight Meglan, Neil Pollack, Matthew Hickey, James Richardson, Ryan Bardsley, Mark P. Ottensmeyer, R. Maxwell Flaherty, J. Christopher Flaherty
  • Publication number: 20060209824
    Abstract: A method, apparatus, and computer program product for propagating broadcast packets among several subnets without configuring routers to forward broadcast packets is provided. The broadcast packets are propagated between subnets as unicast or multicast packets. Further, the broadcast packets are efficiently propagated to only the subnets that desire broadcast propagation.
    Type: Application
    Filed: March 1, 2005
    Publication date: September 21, 2006
    Applicant: The MITRE Corporation
    Inventors: Michael Ross, Matthew Pollack
  • Patent number: 5057598
    Abstract: Novel monoclonal antibodies are disclosed, the production of which is specified by particular genes contained, conveniently, in biologically pure cultures of self-reproducing carrier cells, such as, but not limited to, ATCC HB 8297 and ATCC HB 8298, such antibodies being reactive with at least part of endotoxin core of Gram-negative bacteria. Processes of prepaU.S. GOVERNMENT RIGHTSThe invention described herein may be manufactured, used and licensed by or for the U.S. Government for governmental purposes only without the payment to the inventors of any royalties thereon.
    Type: Grant
    Filed: February 1, 1989
    Date of Patent: October 15, 1991
    Assignee: Centocor, Inc.
    Inventors: Matthew Pollack, Kenneth W. Hunter